Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12756 | 30300287 | Transplantation | Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. | 2019 | Details |
| A12757 | 30300140 | J Clin Invest | Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration. | 2018 | Details |
| A12758 | 30299993 | Expert Opin Pharmacother | Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease. | 2018 | Details |
| A12759 | 30298849 | J Toxicol Sci | Differential impacts of mineralocorticoid receptor antagonist potassium canrenoate on liver and renal changes in high fat diet-mediated early hepatocarcinogenesis model rats. | 2018 | Details |
| A12760 | 30298840 | Nihon Yakurigaku Zasshi | [Gut microbiota and nonalcoholic steatohepatitis]. | 2018 | Details |
| A12761 | 30298839 | Nihon Yakurigaku Zasshi | [The involvement of NOX1/NADPH oxidase in the development of non-alcoholic steatohepatitis]. | 2018 | Details |
| A12762 | 30298748 | Am J Chin Med | Beneficial Effects of Korean Red Ginseng in the Progression of Non-Alcoholic Steatohepatitis via FABP4 Modulation. | 2018 | Details |
| A12763 | 30298568 | Liver Int | Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease. | 2018 | Details |
| A12764 | 30298459 | Obes Surg | Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS). | 2019 | Details |
| A12765 | 30298052 | Front Endocrinol (Lausanne) | The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition. | 2018 | Details |
| A12766 | 30297808 | Nat Commun | Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control. | 2018 | Details |
| A12767 | 30297626 | Int J Mol Sci | Roles of Gut-Derived Secretory Factors in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Their Possible Clinical Applications. | 2018 | Details |
| A12768 | 30297615 | Nutrients | Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics. | 2018 | Details |
| A12769 | 30295948 | Aliment Pharmacol Ther | Liver fat scores predict liver disease mortality in the United States population. | 2018 | Details |
| A12770 | 30295789 | Endocrinology | Adult-Onset Hepatocyte GH Resistance Promotes NASH in Male Mice, Without Severe Systemic Metabolic Dysfunction. | 2018 | Details |
| A12771 | 30294653 | Cell Mol Gastroenterol Hepatol | Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis. | 2018 | Details |
| A12772 | 30294300 | Front Endocrinol (Lausanne) | Developmental Exposure to 2,2',4,4'-Tetrabromodiphenyl Ether Permanently Alters Blood-Liver Balance of Lipids in Male Mice. | 2018 | Details |
| A12773 | 30294278 | Front Physiol | Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. | 2018 | Details |
| A12774 | 30293065 | Ann Nutr Metab | Cholesteryl Ester Transfer Protein Variant (RS1800777) with Liver Histology in Non-Alcoholic Fatty Liver Disease Patients. | 2018 | Details |
| A12775 | 30292582 | Rev Gastroenterol Mex (Engl Ed) | Prevalence of hepatic steatosis and its relation to liver function tests and lipid profile in patients at medical check-up. | 2018 | Details |
| A12776 | 30292566 | Dig Liver Dis | Association between diastolic cardiac dysfunction and nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2018 | Details |
| A12777 | 30292275 | Eur J Radiol | Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease. | 2018 | Details |
| A12778 | 30292107 | J Nutr Biochem | Liraglutide modulates gut microbiota and reduces NAFLD in obese mice. | 2018 | Details |
| A12779 | 30291900 | Drug Discov Today | The future R&D landscape in non-alcoholic steatohepatitis (NASH). | 2018 | Details |
| A12780 | 30291868 | J Hepatol | Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. | 2018 | Details |
| A12781 | 30291215 | Biosci Rep | The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα. | 2018 | Details |
| A12782 | 30290973 | J Hepatol | An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers. | 2018 | Details |
| A12783 | 30288767 | Aliment Pharmacol Ther | Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany. | 2018 | Details |
| A12784 | 30288689 | J Physiol Biochem | Agaricus bisporus supplementation reduces high-fat diet-induced body weight gain and fatty liver development. | 2018 | Details |
| A12785 | 30288477 | Hepatol Commun | Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. | 2018 | Details |
| A12786 | 30288476 | Hepatol Commun | Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12787 | 30288073 | Diabetes Metab Syndr Obes | Obesity and nonalcoholic fatty liver disease: current perspectives. | 2018 | Details |
| A12788 | 30287791 | Int J Mol Sci | Identification of a Novel PPAR-γ Agonist through a Scaffold Tuning Approach. | 2018 | Details |
| A12789 | 30287733 | Nutrients | Achacha (Garcinia humilis) Rind Improves Cardiovascular Function in Rats with Diet-Induced Metabolic Syndrome. | 2018 | Details |
| A12790 | 30287500 | Biosci Rep | Comment on Tauriainen et al.: Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD. | 2018 | Details |
| A12793 | 30286411 | Comput Biol Med | Analysis of microvascular blood flow and oxygenation: Discrimination between two haemodynamic steady states using nonlinear measures and multiscale analysis. | 2018 | Details |
| A12794 | 30285651 | BMC Gastroenterol | Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery. | 2018 | Details |
| A12796 | 30284617 | J Gastroenterol | Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter. | 2018 | Details |
| A12797 | 30284135 | Dig Dis Sci | Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy. | 2018 | Details |
| A12798 | 30283798 | World J Clin Cases | PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease. | 2018 | Details |
| A12799 | 30283242 | Am J Lifestyle Med | Prevention of Diabetes: Countless Opportunities and Clear Challenges. | 2017 | Details |
| A12800 | 30283077 | Int J Obes (Lond) | Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice. | 2018 | Details |
| A12801 | 30282916 | Diseases | Anti-Diabetic Medications for the Pharmacologic Management of NAFLD. | 2018 | Details |
| A12802 | 30282694 | Sci Transl Med | An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo. | 2018 | Details |
| A12803 | 30281809 | Hepatology | LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression. | 2019 | Details |
| A12804 | 30279702 | Front Genet | Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity. | 2018 | Details |
| A12805 | 30275460 | Nat Rev Endocrinol | The role of hypoxia-inducible factors in metabolic diseases. | 2018 | Details |
| A12806 | 30275422 | Int J Mol Sci | Hepatoprotective Effect of Loquat Leaf Flavonoids in PM2.5-Induced Non-Alcoholic Fatty Liver Disease via Regulation of IRs-1/Akt and CYP2E1/JNK Pathways. | 2018 | Details |
| A12807 | 30274911 | Clin Res Hepatol Gastroenterol | Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes. | 2018 | Details |
| A12808 | 30274326 | Diseases | When to Initiate Weight Loss Medications in the NAFLD Population. | 2018 | Details |
| A12809 | 30274215 | J Clin Med | The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass. | 2018 | Details |
| A12810 | 30273934 | Horm Metab Res | Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort. | 2018 | Details |
| A12811 | 30273090 | J Med Food | Aqueous Extract of Humulus japonicus Attenuates Hyperlipidemia and Fatty Liver in Obese Mice. | 2018 | Details |
| A12812 | 30272851 | Asia Pac J Clin Nutr | Pro- and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease. | 2019 | Details |
| A12814 | 30272604 | Gastroenterol Nurs | The Role of the Nurse Practitioner in the Management of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12815 | 30271746 | J Clin Transl Hepatol | The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant. | 2018 | Details |
| A12816 | 30271077 | World J Gastroenterol | Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. | 2018 | Details |
| A12817 | 30270688 | Scand J Gastroenterol | Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study. | 2018 | Details |
| A12818 | 30270343 | Med Sci Monit | Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH). | 2018 | Details |
| A12819 | 30269815 | Biochem Biophys Res Commun | Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet. | 2018 | Details |
| A12820 | 30269271 | Dig Dis Sci | Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis. | 2018 | Details |
| A12821 | 30268890 | Free Radic Biol Med | Mechanisms involved in the death of steatotic WIF-B9 hepatocytes co-exposed to benzo[a]pyrene and ethanol: a possible key role for xenobiotic metabolism and nitric oxide. | 2018 | Details |
| A12822 | 30266645 | Int J Biol Macromol | Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3/6 pathways in a methionine choline deficient diet steatohepatitis mouse model. | 2018 | Details |
| A12823 | 30266576 | Diabetes Metab | Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach. | 2018 | Details |
| A12824 | 30266282 | J Hepatol | Burden of liver diseases in the world. | 2018 | Details |
| A12825 | 30266215 | Ultrasound Med Biol | Experimental Validation of Longitudinal Speed of Sound Estimates in the Diagnosis of Hepatic Steatosis (Part II). | 2018 | Details |
| A12826 | 30266159 | Clin Liver Dis | Nonalcoholic Liver Disease in Children and Adolescents. | 2018 | Details |
| A12827 | 30266038 | Br J Pharmacol | Diethyldithiocarbamate, an anti-abuse drug, alleviates steatohepatitis and fibrosis in rodents through modulating lipid metabolism and oxidative stress. | 2018 | Details |
| A12828 | 30265706 | PLoS One | Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study. | 2018 | Details |
| A12829 | 30265007 | J Proteome Res | d2ome, Software for in Vivo Protein Turnover Analysis Using Heavy Water Labeling and LC-MS, Reveals Alterations of Hepatic Proteome Dynamics in a Mouse Model of NAFLD. | 2018 | Details |
| A12830 | 30264828 | AIDS Rev | Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection | 2018 | Details |
| A12831 | 30263038 | Nutr Metab (Lond) | Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial. | 2018 | Details |
| A12832 | 30262993 | Int J Biol Sci | Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice. | 2018 | Details |
| A12833 | 30262292 | J Trace Elem Med Biol | Low hair copper concentration is related to a high risk of nonalcoholic fatty liver disease in adults. | 2018 | Details |
| A12835 | 30261763 | Expert Rev Gastroenterol Hepatol | An update on the recent advances in antifibrotic therapy. | 2018 | Details |
| A12836 | 30261661 | Int J Mol Sci | Fc Gamma Receptor IIb Expressed in Hepatocytes Promotes Lipid Accumulation and Gluconeogenesis. | 2018 | Details |
| A12837 | 30261472 | Atherosclerosis | Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population. | 2018 | Details |
| A12838 | 30261289 | Biochim Biophys Acta Mol Basis Dis | Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans. | 2018 | Details |
| A12839 | 30260995 | PLoS One | Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis. | 2018 | Details |
| A12840 | 30260782 | Turk J Gastroenterol | Can pancreatic steatosis affect exocrine functions of pancreas? | 2018 | Details |
| A12841 | 30259536 | Hepatology | Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12842 | 30259374 | Adv Exp Med Biol | Circular RNAs in Metabolic Diseases. | 2019 | Details |
| A12843 | 30259280 | Dig Dis Sci | CircScd1 Promotes Fatty Liver Disease via the Janus Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway. | 2018 | Details |
| A12844 | 30258926 | Genes Dis | MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patients. | 2017 | Details |
| A12845 | 30258096 | Lab Invest | Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis. | 2018 | Details |
| A12846 | 30258086 | Exp Mol Med | Role of miR-223 in the pathophysiology of liver diseases. | 2018 | Details |
| A12847 | 30257974 | Diabetes | Insulin Resistance and Vulnerability to Cardiac Ischemia. | 2018 | Details |
| A12849 | 30257633 | Med J Aust | The gut microbiota: cause and cure of gut diseases. | 2018 | Details |
| A12850 | 30257410 | Biomed Pharmacother | Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models. | 2018 | Details |
| A12851 | 30257339 | Biomed Pharmacother | Herbal management of hepatocellular carcinoma through cutting the pathways of the common risk factors. | 2018 | Details |
| A12853 | 30257063 | Liver Transpl | Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease. | 2019 | Details |
| A12854 | 30256948 | Hum Mol Genet | Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia. | 2019 | Details |
| A12856 | 30254132 | Dis Model Mech | A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis. | 2018 | Details |
| A12857 | 30254005 | Acad Radiol | Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight Individuals. | 2018 | Details |
| A12858 | 30253056 | Liver Int | Cardiovascular risk factors in non-alcoholic fatty liver disease. | 2018 | Details |
| A12859 | 30253043 | Liver Int | Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis. | 2019 | Details |
| A12860 | 30252499 | Biomarkers | Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human. | 2018 | Details |
| A12861 | 30252139 | Lipids | Folic Acid Supplementation Attenuates Chronic Hepatic Inflammation in High-Fat Diet Fed Mice. | 2018 | Details |
| A12862 | 30250893 | Mol Cell Oncol | Cisd2 haploinsufficiency: A driving force for hepatocellular carcinoma. | 2018 | Details |
| A12863 | 30250238 | Sci Rep | Human hepatic 3D spheroids as a model for steatosis and insulin resistance. | 2018 | Details |